Skip to main content
. 2022 Sep 22;14(19):4595. doi: 10.3390/cancers14194595

Figure 1.

Figure 1

GNL3L gene expression levels and protein expression levels. Red represents patient samples and blue represents normal samples. (A) Expression of GNL3L gene in ACC, BLCA, BRCA, BRCA−Basal, BRCA−Her2, BRCA−LumA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, HNSC−HPV+, HNSC−HPV−, KICH, KIRC, KIRP, LAML, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, SKCM, metastasis, STAD, TGCT, THCA, THYM, UCEC, UCS, and UVM based on TIMER2 database. (B) Expression of GNL3L gene in DLBC, LAML, LGG, and TGCT based on GEPIA database. (C) Expression of GNL3L protein in breast cancer, clear cell RCC, colon cancer, lung adenocarcinoma, ovarian cancer, and UCEC based on CPTAC database. * p < 0.05; ** p < 0.01 and *** p < 0.001.